Skip to contentROBERTSON REBECCA B — Neutral Tandem Inc insider: 94 transactions · InsiderLensROBERTSON REBECCA B
- Former 10% Holder at Alexza Pharmaceuticals Inc. · on record since Mar 14, 2006
- 10% owner at Alexza Pharmaceuticals Inc. · on record since Mar 8, 2006
- 10% owner at NOVACEA INC · on record since May 15, 2006
- 10% owner at HELICOS BIOSCIENCES CORP · on record since May 24, 2007
- Former 10% Owner at INSULET CORP · on record since May 17, 2007
- 10% owner at INSULET CORP · on record since May 14, 2007
- Affiliate of 10% owner at @ROAD, INC · on record since Aug 21, 2003
- affiliate of 10% owner at Regency Resources, Inc. · on record since Sep 11, 2003
- Director at Neutral Tandem Inc · on record since May 22, 2026
- Director at Ceribell, Inc. · on record since Jun 4, 2026
- Director at Flexion Therapeutics Inc · on record since Sep 12, 2014
- 10% owner at Flexion Therapeutics Inc · on record since Sep 12, 2014
- 10% owner at INTROGEN THERAPEUTICS INC · on record since Dec 29, 2014
- 10% owner at Vivani Medical, Inc. · on record since Nov 18, 2014
- 10% owner at GLAUKOS Corp · on record since Jun 30, 2015
- 10% owner at INTRALASE CORP · on record since Oct 6, 2004
- 10% owner at PHASERX, INC. · on record since May 24, 2016
- former 10% owner at GLAUKOS Corp · on record since Jun 2, 2016
- 10% owner at GENOMIC HEALTH INC · on record since Sep 28, 2005
Insider trading activity of ROBERTSON REBECCA B
- Transactions on record
- 94
- since Oct 5, 2005
- Open-market buys
- 1
- $624.3K
- Open-market sells
- 24
- $2.9M
- Companies traded
- 4
- last filing Jun 4, 2026
Figures computed from official regulatory filings — methodology.
Companies where ROBERTSON REBECCA B has traded
Track record of ROBERTSON REBECCA B
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of ROBERTSON REBECCA B
Co-insiders of ROBERTSON REBECCA B
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Warden Charles MAlexza Pharmaceuticals Inc. +6
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 4, 2026 | Award | 7,838 | 0.00 USD | $0 | SEC |
| May 22, 2026 | ExerciseD | -8,759 | 0.00 USD | $0 | SEC |
| May 22, 2026 | AwardD | 10,220 | 0.00 USD | $0 | SEC |
| May 22, 2026 | Exercise | 8,759 | 0.00 USD | $0 | SEC |
| Mar 5, 2026 | Sell | -827 | 17.80 USD | $14.7K | SEC |
| Jan 6, 2026 | Exercise | 2,500 | 2.24 USD | $5.6K | SEC |
| Jan 6, 2026 | Sell | -7,445 | 17.63 USD | $131.3K | SEC |
| Jan 6, 2026 | ExerciseD | -2,500 | 0.00 USD | $0 | SEC |
| Jan 6, 2026 | Sell | -2,500 | 21.89 USD | $54.7K | SEC |
| Dec 10, 2025 | Exercise | 5,000 | 2.24 USD | $11.2K | SEC |
| Dec 10, 2025 | Sell | -5,000 | 20.00 USD | $100K | SEC |
| Dec 10, 2025 | ExerciseD | -5,000 | 0.00 USD | $0 | SEC |
| Dec 4, 2025 | Sell | -827 | 16.67 USD | $13.8K | SEC |
| Sep 5, 2025 | Sell | -827 | 11.36 USD | $9.4K | SEC |
| Jun 17, 2025 | ExerciseD | -19,455 | 0.00 USD | $0 | SEC |
| Jun 17, 2025 | Sell | -20,000 | 17.14 USD | $342.8K | SEC |
| Jun 17, 2025 | Award | 8,828 | 0.00 USD | $0 | SEC |
| Jun 17, 2025 | ExerciseD | -545 | 0.00 USD | $0 | SEC |
| Jun 17, 2025 | Exercise | 19,455 | 3.65 USD | $71K | SEC |
| Jun 17, 2025 | Exercise | 545 | 2.24 USD | $1.2K | SEC |
| May 23, 2025 | AwardD | 8,759 | 0.00 USD | $0 | SEC |
| May 23, 2025 | Exercise | 4,387 | 20.64 USD | $90.5K | SEC |
| May 23, 2025 | ExerciseD | -4,387 | 0.00 USD | $0 | SEC |
| Oct 16, 2024 | Award | 6,618 | 0.00 USD | $0 | SEC |
| May 24, 2024 | AwardD | 4,387 | 0.00 USD | $0 | SEC |